Recruiting studies: Dfnb9

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Otoferlin Gene-mediated Hearing Loss Natural History Study
Phase N/A · 10 location(s) · Akouos, Inc. · NCT05572073 A Study of EH002 Gene Therapy for Otoferlin Gene Mutation-mediated Hearing Loss
NA · 2 location(s) · Yilai Shu · NCT06722170 Natural History in Children up to 16 Years With Mild to Profound Hearing Loss Due to Mutations in GJB2 / OTOF Genes
Phase N/A · 1 location(s) · Sensorion · NCT05402813 A Comparative Analysis of Speech Perception Between Cochlear Implant Patients and DFNB9 Patients Receiving Gene Therapy
Phase N/A · 6 location(s) · Eye & ENT Hospital of Fudan University · NCT06237790 A Study of DB-OTO, an Adeno-Associated Virus (AAV) Based Gene Therapy, in Children/Infants, Adolescents and Adults With
Phase 1/Phase 2 · 16 location(s) · Regeneron Pharmaceuticals · NCT05788536 Otoferlin Patient Registry and Natural History Study
Phase N/A · 1 location(s) · Tobias Moser · NCT05946057 A Clinical Trial of EHT102 Injection in Pediatric Patients With Biallelic hOTOF Mutations
Phase 1/Phase 2 · 1 location(s) · Shanghai Euhearing Therapeutics Co., Ltd · NCT07288580 Gene Therapy Trial for Otoferlin Gene-mediated Hearing Loss
Phase 1/Phase 2 · 9 location(s) · Akouos, Inc. · NCT05821959

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.